Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial.
第一作者:
Aaron Guanliang,Lim
第一单位:
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
作者:
主题词
人类(Humans);肝炎病毒属(Hepacivirus);费用效益分析(Cost-Benefit Analysis);抗病毒药(Antiviral Agents);物质滥用, 静脉内(Substance Abuse, Intravenous);丙型肝炎, 慢性(Hepatitis C, Chronic);吸毒者(Drug Users);丙型肝炎(Hepatitis C);挪威(Norway);质量校正寿命(Quality-Adjusted Life Years)
DOI
10.1111/add.16305
PMID
37515462
发布时间
2024-03-22
- 浏览0

Addiction (Abingdon, England)
2424-2439页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文